Liquid Biopsy Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Liquid Biopsy Market, By Technology

7.1. Liquid Biopsy Market, by Technology, 2024-2033

7.1.1. NGS

7.1.1.1. Market Revenue and Forecast (2021-2033)

7.1.2. PCR

7.1.2.1. Market Revenue and Forecast (2021-2033)

7.1.3. FISH

7.1.3.1. Market Revenue and Forecast (2021-2033)

7.1.4. Other

7.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 8. Global Liquid Biopsy Market, By Usage

8.1. Liquid Biopsy Market, by Usage, 2024-2033

8.1.1. RUO

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Clinical

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Liquid Biopsy Market, By Types of Sample

9.1. Liquid Biopsy Market, by Types of Sample, 2024-2033

9.1.1. Blood

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Urine

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Saliva

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. CerebroSpinal Fluid

9.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Liquid Biopsy Market, By Circulating Biomarker

10.1. Liquid Biopsy Market, by Circulating Biomarker, 2024-2033

10.1.1. Circulating Tumor Cells

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Cell-free DNA

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Circulating Cell-Free RNA

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Exosomes and Extracellular Vesicles

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Liquid Biopsy Market, By Products

11.1. Liquid Biopsy Market, by Products, 2024-2033

11.1.1. Test/Services

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Kits and Consumable

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Instruments

11.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Liquid Biopsy Market, By Indication Type

12.1. Liquid Biopsy Market, by Indication Type, 2024-2033

12.1.1. Lung Cancer

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. Breast Cancer

12.1.2.1. Market Revenue and Forecast (2021-2033)

12.1.3. Prostate Cancer

12.1.3.1. Market Revenue and Forecast (2021-2033)

12.1.4. Colorectal Cancer

12.1.4.1. Market Revenue and Forecast (2021-2033)

12.1.5. Melanoma

12.1.5.1. Market Revenue and Forecast (2021-2033)

12.1.6. Other cancers

12.1.6.1. Market Revenue and Forecast (2021-2033)

12.1.7. Non-Oncology Disorders

12.1.7.1. Market Revenue and Forecast (2021-2033)

Chapter 13. Global Liquid Biopsy Market, By Clinical Application

13.1. Liquid Biopsy Market, by Clinical Application, 2024-2033

13.1.1. Treatment Monitoring

13.1.1.1. Market Revenue and Forecast (2021-2033)

13.1.2. Prognosis and Recurrence Monitoring

13.1.2.1. Market Revenue and Forecast (2021-2033)

13.1.3. Treatment Selection

13.1.3.1. Market Revenue and Forecast (2021-2033)

13.1.4. Diagnosis and Screening

13.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 14. Global Liquid Biopsy Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Technology (2021-2033)

14.1.2. Market Revenue and Forecast, by Usage (2021-2033)

14.1.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.1.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.1.5. Market Revenue and Forecast, by Products (2021-2033)

14.1.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.1.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.1.8. U.S.

14.1.8.1. Market Revenue and Forecast, by Technology (2021-2033)

14.1.8.2. Market Revenue and Forecast, by Usage (2021-2033)

14.1.8.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.1.8.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.1.8.5. Market Revenue and Forecast, by Products (2021-2033)

14.1.8.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.1.8.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Technology (2021-2033)

14.1.9.2. Market Revenue and Forecast, by Usage (2021-2033)

14.1.9.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.1.9.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.1.9.5. Market Revenue and Forecast, by Products (2021-2033)

14.1.9.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.1.9.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.2. Europe

14.2.1. Market Revenue and Forecast, by Technology (2021-2033)

14.2.2. Market Revenue and Forecast, by Usage (2021-2033)

14.2.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.2.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.2.5. Market Revenue and Forecast, by Products (2021-2033)

14.2.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.2.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Technology (2021-2033)

14.2.8.2. Market Revenue and Forecast, by Usage (2021-2033)

14.2.8.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.2.8.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.2.8.5. Market Revenue and Forecast, by Products (2021-2033)

14.2.8.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.2.8.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.2.9. Germany

14.2.9.1. Market Revenue and Forecast, by Technology (2021-2033)

14.2.9.2. Market Revenue and Forecast, by Usage (2021-2033)

14.2.9.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.2.9.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.2.9.5. Market Revenue and Forecast, by Products (2021-2033)

14.2.9.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.2.9.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.2.10. France

14.2.10.1. Market Revenue and Forecast, by Technology (2021-2033)

14.2.10.2. Market Revenue and Forecast, by Usage (2021-2033)

14.2.10.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.2.10.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.2.10.5. Market Revenue and Forecast, by Products (2021-2033)

14.2.10.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.2.10.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Forecast, by Technology (2021-2033)

14.2.11.2. Market Revenue and Forecast, by Usage (2021-2033)

14.2.11.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.2.11.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.2.11.5. Market Revenue and Forecast, by Products (2021-2033)

14.2.11.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.2.11.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Technology (2021-2033)

14.3.2. Market Revenue and Forecast, by Usage (2021-2033)

14.3.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.3.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.3.5. Market Revenue and Forecast, by Products (2021-2033)

14.3.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.3.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.3.8. India

14.3.8.1. Market Revenue and Forecast, by Technology (2021-2033)

14.3.8.2. Market Revenue and Forecast, by Usage (2021-2033)

14.3.8.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.3.8.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.3.8.5. Market Revenue and Forecast, by Products (2021-2033)

14.3.8.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.3.8.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.3.9. China

14.3.9.1. Market Revenue and Forecast, by Technology (2021-2033)

14.3.9.2. Market Revenue and Forecast, by Usage (2021-2033)

14.3.9.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.3.9.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.3.9.5. Market Revenue and Forecast, by Products (2021-2033)

14.3.9.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.3.9.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.3.10. Japan

14.3.10.1. Market Revenue and Forecast, by Technology (2021-2033)

14.3.10.2. Market Revenue and Forecast, by Usage (2021-2033)

14.3.10.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.3.10.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.3.10.5. Market Revenue and Forecast, by Products (2021-2033)

14.3.10.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.3.10.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Forecast, by Technology (2021-2033)

14.3.11.2. Market Revenue and Forecast, by Usage (2021-2033)

14.3.11.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.3.11.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.3.11.5. Market Revenue and Forecast, by Products (2021-2033)

14.3.11.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.3.11.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Technology (2021-2033)

14.4.2. Market Revenue and Forecast, by Usage (2021-2033)

14.4.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.4.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.4.5. Market Revenue and Forecast, by Products (2021-2033)

14.4.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.4.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.4.8. GCC

14.4.8.1. Market Revenue and Forecast, by Technology (2021-2033)

14.4.8.2. Market Revenue and Forecast, by Usage (2021-2033)

14.4.8.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.4.8.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.4.8.5. Market Revenue and Forecast, by Products (2021-2033)

14.4.8.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.4.8.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.4.9. North Africa

14.4.9.1. Market Revenue and Forecast, by Technology (2021-2033)

14.4.9.2. Market Revenue and Forecast, by Usage (2021-2033)

14.4.9.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.4.9.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.4.9.5. Market Revenue and Forecast, by Products (2021-2033)

14.4.9.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.4.9.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.4.10. South Africa

14.4.10.1. Market Revenue and Forecast, by Technology (2021-2033)

14.4.10.2. Market Revenue and Forecast, by Usage (2021-2033)

14.4.10.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.4.10.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.4.10.5. Market Revenue and Forecast, by Products (2021-2033)

14.4.10.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.4.10.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Forecast, by Technology (2021-2033)

14.4.11.2. Market Revenue and Forecast, by Usage (2021-2033)

14.4.11.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.4.11.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.4.11.5. Market Revenue and Forecast, by Products (2021-2033)

14.4.11.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.4.11.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Technology (2021-2033)

14.5.2. Market Revenue and Forecast, by Usage (2021-2033)

14.5.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.5.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.5.5. Market Revenue and Forecast, by Products (2021-2033)

14.5.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.5.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.5.8. Brazil

14.5.8.1. Market Revenue and Forecast, by Technology (2021-2033)

14.5.8.2. Market Revenue and Forecast, by Usage (2021-2033)

14.5.8.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.5.8.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.5.8.5. Market Revenue and Forecast, by Products (2021-2033)

14.5.8.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.5.8.7. Market Revenue and Forecast, by Indication Type (2021-2033)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Technology (2021-2033)

14.5.9.2. Market Revenue and Forecast, by Usage (2021-2033)

14.5.9.3. Market Revenue and Forecast, by Types of Sample (2021-2033)

14.5.9.4. Market Revenue and Forecast, by Circulating Biomarker (2021-2033)

14.5.9.5. Market Revenue and Forecast, by Products (2021-2033)

14.5.9.6. Market Revenue and Forecast, by Clinical Application (2021-2033)

14.5.9.7. Market Revenue and Forecast, by Indication Type (2021-2033)

Chapter 15. Company Profiles

15.1. Bio-Rad Laboratories

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Biocept Inc.

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Guardant Health

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Illumina, Inc.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. F. Hoffmann-La Roche Ltd.

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Johnson & Johnson

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Laboratory Corporation of America Holdings

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. MDxHealth SA

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. QIAGEN N.V

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Thermo Fisher Scientific Inc.

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms